logo

For the Inventor, By the Inventor

Hanover, Germany

Gerd Buschmann

USPTO Granted Patents = 15

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal15 out of 92 
 
Kali-chemie Pharma Gmbh
 patents

Years Active: 1983-1992

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5164401 - Method of diuretic treatment with 3,7-diazabicyclo[3,3,1]nonane compounds (1992-11-17),
2. 4924004 - 1-phenyl-2-aminocarbonylindole compounds, preparation thereof and (1990-05-08),
3. 4912113 - 3,7-diazabicyclo(3,3,1)nonane compounds and pharmaceutical compositions (1990-03-27),
4. 4879299 - Treatment of heart conditions with spartein compounds (1989-11-07),
5. 4814345 - 1-phenyl-2-aminocarbonylindole compounds, preparation thereof and (1989-03-21),
6. 4803198 - 1-Phenyl-2-aminocarbonylindole compounds, preparation thereof and (1989-02-07),
7. 4755520 - Spartein compounds, their preparation and use (1988-07-05),
8. 4742172 - Intermediates for synthesizing pharmaceutically active (1988-05-03),
9. 4714709 - N-(2,10-dioxa-tricyclo-[5,3,1,0.sup.3,8 ]-undecane-5-yl)-tryptamine (1987-12-22),
10. 4695566 - 3-aminocarbonylmethoxy-5-phenylpyrazole compounds, antiarrythmic (1987-09-22),
11. 4554274 - N.sub.b Quaternary derivatives of ajmaline and isoajmaline, methods and (1985-11-19),
12. 4552877 - N.sub.b -Quaternary derivatives of sandwicine and isosandwicine methods (1985-11-12),
13. 4550112 - 3,7-Diazabicyclo(3,3,1)nonane compounds and their use in treating heart (1985-10-29),
14. 4451468 - Acidiferous 17-normal-pentyl sparteine tartaric and fumaric acid salts (1984-05-29),
15. 4415577 - Bis-sparteine derivatives and method of using same in therapy (1983-11-15),

Title: Gerd Buschmann: An Innovative Mind in Pharmaceuticals

Introduction:

Gerd Buschmann, a talented inventor and researcher based in Hanover, Germany, has made significant contributions to the field of pharmaceuticals. With over 15 patents to his name, Buschmann has demonstrated his expertise in developing novel compounds and treatment methods. This article will explore his latest patents, career highlights, collaborations, and the valuable contributions he has made to the field of pharmaceuticals.

Latest Patents:

Buschmann's latest patents highlight his pioneering work in developing effective diuretic treatments and antiarrhythmic compounds. One of his notable patents is the "Method of Diuretic Treatment with 3,7-diazabicyclo[3,3,1]nonane Compounds." This patent presents a method of treating mammals in need of diuretic treatment by administering diuretically active compounds. The invention holds potential for addressing various conditions where diuretic treatment is necessary.

Another notable patent by Buschmann is the discovery of "1-phenyl-2-aminocarbonylindole Compounds." These compounds exhibit pharmacological properties, particularly in relation to antiarrhythmic effects. The patent not only provides a detailed description of the compounds but also describes their synthesis and the pharmaceutical compositions containing them.

Career Highlights:

Gerd Buschmann has dedicated his career to research and innovation in the pharmaceutical industry. He has been associated with Kali-chemie Pharma GmbH, a renowned pharmaceutical company known for its groundbreaking contributions. As a key member of the research and development team at Kali-chemie Pharma, Buschmann has played an instrumental role in bringing novel medications to the market.

Collaborations:

Innovation thrives through collaborative efforts, and Gerd Buschmann has shown a strong inclination towards teamwork. Throughout his career, Buschmann has collaborated with prominent scientists and researchers. Some of his notable coworkers include Ulrich G. Kuehl and Wolfgang Kehrbach. These collaborations have not only enhanced Buschmann's inventive capabilities but have also fostered knowledge exchange and facilitated groundbreaking advancements in pharmaceutical research.

Conclusion:

Gerd Buschmann's contributions to the field of pharmaceuticals through his numerous patents and pioneering research have been significant. His latest patents demonstrate his expertise in developing effective diuretic treatments and antiarrhythmic compounds. As a part of Kali-chemie Pharma GmbH, Buschmann has been an integral part of a team that continuously strives to improve medical treatments. With his collaborative spirit and dedication to innovation, Buschmann continues to shape the landscape of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…